Adenosine 2b receptor (A2bR) signals through adenylate cyclase (AC) 6 isoform in the intestinal epithelial cells.
Adenosine 2b receptor (A2bR), a G-protein coupled receptor positively coupled to adenylate cyclase, mediates key events such as chloride, IL-6 and fibronectin secretion in intestinal epithelial cells and is upregulated during intestinal inflammation. In order to gain insight into the overall mechanism of A2bR activation, in this study, we sought to characterize the AC isoform associated with A2bR signaling. The colonic epithelial cell line T84, expressing only the A2b subtype of adenosine receptor, and Chinese hamster ovary (CHO) cells, were used in these studies. cAMP was measured by luminometric assay and AC isoform expression was determined by Western blot, RT-PCR, isoform-specific stealth RNAi and Quantigene. T84 and CHO cells express all nine known AC isoforms. In order to characterize which AC isoform(s) are associated with A2bR, we used the differential inhibition of specific AC isoforms by calcium and nitric oxide. Pretreatment of cells with carbachol or nitric oxide donors such as S-Nitroso-N-acetylpencillamine (SNAP) and PAPANANOATE inhibited A2bR mediated increase in cAMP. Further, overexpression of AC-5 or AC-6 potentiated A2bR-mediated increases in cAMP levels. Finally, transfection with AC isoform-specific RNAi demonstrated that AC-6 but not AC-5 RNAi inhibited adenosine-induced cAMP levels. Taken together, these results suggest that A2bR mediates signaling through AC-6 isoform. Since pro-inflammatory cytokines such as interferon-gamma (IFN-gamma) modulate the expression of specific AC isoforms in the intestinal epithelia, our observation may have therapeutic implications for intestinal inflammation or diarrhea wherein aA2bR is upregulated.
Kolachala
Vasantha L
VL
Division of Digestive Diseases, Department of Medicine, Emory University, Room 201-F, 615 Michael Street, Whitehead Research Building, Atlanta, GA 30322, USA.
Obertone
Tracy Sitler
TS
Wang
Lixin
L
Merlin
Didier
D
Sitaraman
Shanthi V
SV
D000241:Adenosine / Q000737:chemistry; D000262:Adenylyl Cyclases / Q000737:chemistry*; D000818:Animals; D016466:CHO Cells; D002217:Carbachol / Q000494:pharmacology; D018679:Cholinergic Agonists / Q000494:pharmacology; D006224:Cricetinae; D004847:Epithelial Cells / Q000378:metabolism*; D006801:Humans; D007249:Inflammation; D007422:Intestines / Q000166:cytology*; D009569:Nitric Oxide / Q000737:chemistry / Q000378:metabolism; D010957:Plasmids / Q000378:metabolism; D020033:Protein Isoforms; D043704:Receptor, Adenosine A2B / Q000378:metabolism*; D014162:Transfection
D018679:Cholinergic Agonists; D020033:Protein Isoforms; D043704:Receptor, Adenosine A2B; D009569:Nitric Oxide; D002217:Carbachol; D000262:Adenylyl Cyclases; D000241:Adenosine